Wallin I - Search Results

1

The kinetics and cytotoxicity of cisplatin and its monohydrated complex.

Yachnin JR, Wallin I, Lewensohn R, Sirzén F, Ehrsson H. Yachnin JR, et al. Among authors: wallin i. Cancer Lett. 1998 Oct 23;132(1-2):175-80. doi: 10.1016/s0304-3835(98)00175-x. Cancer Lett. 1998. PMID: 10397471

2

Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.

Ekborn A, Lindberg A, Laurell G, Wallin I, Eksborg S, Ehrsson H. Ekborn A, et al. Among authors: wallin i. Cancer Chemother Pharmacol. 2003 Jan;51(1):36-42. doi: 10.1007/s00280-002-0540-5. Epub 2002 Nov 2. Cancer Chemother Pharmacol. 2003. PMID: 12497204

3

Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.

Videhult P, Laurell G, Wallin I, Ehrsson H. Videhult P, et al. Among authors: wallin i. Exp Biol Med (Maywood). 2006 Nov;231(10):1638-45. doi: 10.1177/153537020623101009. Exp Biol Med (Maywood). 2006. PMID: 17060685

4

D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics.

Ekborn A, Laurell G, Johnström P, Wallin I, Eksborg S, Ehrsson H. Ekborn A, et al. Among authors: wallin i. Hear Res. 2002 Mar;165(1-2):53-61. doi: 10.1016/s0378-5955(02)00277-0. Hear Res. 2002. PMID: 12031515

5

Liquid chromatographic determination of oxaliplatin in blood using post-column derivatization in a microwave field followed by photometric detection.

Ehrsson H, Wallin I. Ehrsson H, et al. Among authors: wallin i. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct 5;795(2):291-4. doi: 10.1016/s1570-0232(03)00590-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 14522033

6

Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.

Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Jerremalm E, et al. Among authors: wallin i. Pharm Res. 2004 May;21(5):891-4. doi: 10.1023/b:pham.0000026444.67883.83. Pharm Res. 2004. PMID: 15180350

7

High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.

Ekborn A, Hansson J, Ehrsson H, Eksborg S, Wallin I, Wagenius G, Laurell G. Ekborn A, et al. Among authors: wallin i. Laryngoscope. 2004 Sep;114(9):1660-7. doi: 10.1097/00005537-200409000-00030. Laryngoscope. 2004. PMID: 15475801

8

Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.

Jerremalm E, Wallin I, Yachnin J, Ehrsson H. Jerremalm E, et al. Among authors: wallin i. Eur J Pharm Sci. 2006 Jul;28(4):278-83. doi: 10.1016/j.ejps.2006.03.001. Epub 2006 Apr 18. Eur J Pharm Sci. 2006. PMID: 16621479

9

Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.

Hellberg V, Wallin I, Eriksson S, Hernlund E, Jerremalm E, Berndtsson M, Eksborg S, Arnér ES, Shoshan M, Ehrsson H, Laurell G. Hellberg V, et al. Among authors: wallin i. J Natl Cancer Inst. 2009 Jan 7;101(1):37-47. doi: 10.1093/jnci/djn418. Epub 2008 Dec 30. J Natl Cancer Inst. 2009. PMID: 19116379 Free PMC article.

10

Quantitative liquid chromatographic determination of intact cisplatin in blood with microwave-assisted post-column derivatization and UV detection.

Pierre PV, Wallin I, Eksborg S, Ehrsson H. Pierre PV, et al. Among authors: wallin i. J Pharm Biomed Anal. 2011 Aug 25;56(1):126-30. doi: 10.1016/j.jpba.2011.04.028. Epub 2011 May 31. J Pharm Biomed Anal. 2011. PMID: 21621941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters